Technical Analysis for CATB - Catabasis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 0.84 1.20% 0.01
CATB closed up 1.2 percent on Friday, September 21, 2018, on 1.16 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical CATB trend table...

Date Alert Name Type % Chg
Sep 21 180 Bullish Setup Bullish Swing Setup 0.00%
Sep 21 Stochastic Reached Overbought Strength 0.00%
Sep 21 Overbought Stochastic Strength 0.00%
Sep 21 Up 3 Days in a Row Strength 0.00%
Sep 21 Up 4 Days in a Row Strength 0.00%
Sep 20 Shooting Star Candlestick Bearish 1.20%
Sep 20 Lizard Bearish Bearish Day Trade Setup 1.20%
Sep 20 Pocket Pivot Bullish Swing Setup 1.20%
Sep 20 Doji - Bearish? Reversal 1.20%
Sep 20 Up 3 Days in a Row Strength 1.20%

Older signals for CATB ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Catabasis Pharmaceuticals, Inc. (Catabasis) is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapeutics based on its safely metabolized and rationally targeted (SMART) linker technology platform. Its SMART linker technology platform is based on the concept of treating diseases by simultaneously modulating various biological targets in one or more related disease pathways. Catabasis engineers bi-functional product candidates that are conjugates of two molecules, or bioactives, each with known pharmacological activity, joined by one of its SMART linkers. Catabasis is also engaged in developing other product candidates for the treatment of lipid disorders. The Company's product development pipeline includes three clinical-stage product candidates, namely, CAT-1004, CAT-2000 series, including CAT-2054 and CAT-2003, and CAT-4001, and various programs in preclinical development.
Is CATB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.78
52 Week Low 0.61
Average Volume 966,753
200-Day Moving Average 1.3558
50-Day Moving Average 0.7206
20-Day Moving Average 0.7641
10-Day Moving Average 0.791
Average True Range 0.0615
ADX 22.76
+DI 25.3364
-DI 16.0789
Chandelier Exit (Long, 3 ATRs ) 0.6755
Chandelier Exit (Short, 3 ATRs ) 0.8245
Upper Bollinger Band 0.8468
Lower Bollinger Band 0.6814
Percent B (%b) 0.96
BandWidth 21.646381
MACD Line 0.0238
MACD Signal Line 0.0134
MACD Histogram 0.0104
Fundamentals Value
Market Cap 18.88 Million
Num Shares 22.5 Million
EPS -1.71
Price-to-Earnings (P/E) Ratio -0.49
Price-to-Sales 0.00
Price-to-Book 2.17
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.92
Resistance 3 (R3) 0.91 0.87 0.90
Resistance 2 (R2) 0.87 0.85 0.88 0.90
Resistance 1 (R1) 0.86 0.84 0.87 0.87 0.89
Pivot Point 0.82 0.82 0.83 0.83 0.82
Support 1 (S1) 0.81 0.80 0.82 0.82 0.79
Support 2 (S2) 0.77 0.79 0.78 0.78
Support 3 (S3) 0.76 0.77 0.78
Support 4 (S4) 0.77